Stocks

NOVN Stock: Novan surges in after hours trading on patent grant

NOVN Stock: Novan surges in after hours trading on patent grant

Shares of Novan (NOVN) surged 23% in after hours trading, the company is soon the be the world’s first FDA approved Molluscum drug developer.

According to the U.S. Patent and Trademark Office file, Novan is to be issued US Patent No. 10,925,689 on 2/23 by the USPTO, The patent is titled: NITRIC OXIDE RELEASING NAIL COATING COMPOSITIONS, NITRIC OXIDE RELEASING NAIL COATINGS, AND METHODS OF USING THE SAME.